Combination Drug/Device Products CGMPs - Final Rule

  • Speaker:Dr. David Lim
  • Date: 30th June 2017 10:00 AM PST | 01:00 PM EST
  • Duration:60Min
  • Product Code:GRC-90151

$179

refer

Refer Friend's


Live Session - How it works

  • Username and Password will be sent to you 24 hours prior to the webinar.
  • Presentation handouts in pdf format will be mailed to you.
  • Login to the session using the username and password provided to you.
  • Get answer to your queries through interactive Q&A sessions via chat.
  • Please let us know your thoughts and views at the end of webinar, your valuable feedback will help us improve.
  • Get certification of attendance.

Recorded Session - How it works

  • Login Information with Password to view the webinar, 24 hours after the Live webinar (link valid for 6 months).
  • A link will be provided to you upon purchase of the recorded session.
  • Please click on the link to access the session.
  • Presentation handouts in pdf format will be mailed to you.
  • Get certification of attendance.

Training CD - How it works

  • Free shipment within 72 Hours, from the date of webinar completion.

(More about our products contact +1- 248-233-2049)

Description:

This webinar will discuss the US’s FDA Final Rule for current Good Manufacturing Practices (CGMPs) for combination products. In particular, it is intended to better understand the cGMP requirements for enforcement purposes.
Both domestic and foreign manufacturers are required to establish and maintain a quality management system (QMS) to the extent applicable for combination products (e.g., drug and medical device).  The speaker will discuss how firms can achieve compliance with quality system regulations as well as how to achieve compliance with drug cGMP requirements for combination products.  For example, do design controls apply when a device constituent part is used in a combination product?  If so, what levels of design control would apply?
To achieve compliance and to remain compliant with the cGMP requirements applicable for combination products, it is critical that executives and managers understand and accurately interpret the applicable requirements so that compliance to cGMP requirements can be adequately, sustainably achieved.

This webinar will provide a great opportunity to get familiar with the cGMP requirements and greatly improve your awareness and confidence.

Areas To Be Covered in this Seminar:
•    Applicable Laws and Regulations
•    Definitions
•    Current Good Manufacturing Practice (cGMP) Final Rule for Combination Products
•    cGMP Requirements for A Co-Packaged Or Single entity Combination Product
•    Implementing Compliance to Quality System Regulations
•    Implementing Compliance to Drug cGMP Requirements
•    Implementing Compliance to Biological Product and HCT/P Requirements
•    Comparative Discussion on 21 CFR Parts 210/211, 600-680, 820, and 1271
•    Common Misconceptions
•    How to implement cGMPs for Combination Products
•    Best Practices: Dos and Don’ts
•    Speaker’s PASS-IT Recommendations

Who will benefit:
•    CEOs
•    VPs
•    Compliance Officers
•    Attorneys
•    Regulatory Affairs
•    Clinical Affairs
•    Quality Assurance
•    R&D
•    Consultants
•    Contractors/Subcontractors
•    Anyone Interested in the FDA Drug Review and Approval Processes

Instructor Profile:

Dr. David Lim, Ph.D., RAC, ASQ-CQA.  Dr. Lim is President and Principal of Regulatory Doctor (www.RegulatoryDoctor.us).  As a leading industry speaker, Dr. Lim frequently presents global regulatory and quality compliance topics in various forums and meetings.  Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, Dr. Lim developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past eight years.  Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009. 
Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker.  Dr. Lim leads and directs all research projects including pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor. 

Available Options

Live Meeting Access: Attend the meeting Live via Webex

$179

Live Meeting Access: Attend the meeting Live via Webex

Recording: Access it for 6 months from any location

$209

CD: Shipped within 2 working days

$339

Live + Recording: Attend Live + Access the recording for 6 months

$349

Live + CD: Attend Live + Get a copy of the CD of the webinar

$459

5 Member Group: Access the Live Meeting online from any location globally

$629

10 Member group: Access the Live Meeting online from any location globally

$1,499
For discounts and offers call support